refractory multiple myeloma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (12)

Phase 1 (6)
Phase 1/2 (2)
Phase 3 (1)
Unknown (3)

Interventional (10)
Observational (2)

Sanofi (5)
Chongqing Precision Biotech Co., Ltd (2)
CRISPR Therapeutics AG (1)
Genentech, Inc. (1)
GlaxoSmithKline (1)
Hebei Senlang Biotechnology Inc., Ltd. (1)
Juno Therapeutics, a Subsidiary of Celgene (1)

No (12)

No (12)

Adult (18+) (12)

I am/have/had

I am/have/hadmultiple myeloma

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadrefractory multiple myeloma

I am/have/hadcell transplantation

I am/have/hadrecurrent disease

I am/have/hadarrhythmia

I am/have/hadneuropathy

I am/have/hadhair thinning

I am/have/hadhodgkin's disease

I am/have/hadchronic lymphocytic leukemia

I am/have/hadejection fraction

I am/have/hadlymphoma

I am/have/hadct scan

I am/have/hadcarcinoma

I am/have/hadantibiotic therapy

I am/have/hadcancer treatment

I am/have/hadfollicular lymphoma

I am/have/hadimmunohistochemistry

I am/have/hadflow cytometry

added new label for I am/have/had

more

I am looking for

I am looking formonoclonal antibodies

I am looking fordexamethasone

I am looking formonoclonal protein

I am looking forbortezomib

I am looking forlenalidomide

I am looking forcarfilzomib

I am looking forpomalidomide

I am looking forproteasome inhibitor

I am looking fordaratumumab

I am looking forthalidomide

I am looking forcorticosteroids

I am looking forixazomib

I am looking forbcma

I am looking forhepatitis b surface antigen

I am looking forantibiotics

I am looking forisatuximab

I am looking forantibiotic

I am looking forimmunotherapeutic agent

I am looking forbelantamab mafodotin

I am looking forimmunomodulators

added new label for I am looking for

more

Advanced Filters

Loading...

Found 12 clinical trials

Multi-country trial
For Seniors
For adults
Recruiting in 1000s
Observational Study
all
Family Medicine
Recruiting

A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

isatuximab

refractory multiple myeloma

multiple myeloma

complete resection

carcinoma

0 views
19 Feb, 2024
4 locations

Multi-country trial
For Seniors
For adults
Recruiting in 1000s
Observational Study
all
Family Medicine
Recruiting

A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

isatuximab

refractory multiple myeloma

multiple myeloma

complete resection

carcinoma

0 views
19 Feb, 2024
10 locations

1
2

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.